Stereotaxis announced a partnership with Kansas City Heart Rhythm Institute to bring new and cutting-edge treatments to arrhythmia patients. Kansas City Heart Rhythm Institute (KCHRI) will establish a new program which will be based at Overland Park Regional Medical Center to expand access to advanced robotic technology for the treatment of cardiac arrhythmias. KCHRI is the premier arrhythmia care institution serving the greater Midwest through world class clinical care, education and research. This mission is supported through the acquisition of Stereotaxis’ advanced robotic technology, along with large-screen display and connectivity solutions. The system is expected to be installed and operational in the second half of 2019.